Naprius

Naproxen

Naprius

Active substance

Naproxen

Strenght and pharmaceutical forms

500 mg Granulate for oral suspension - 20 sachets
10% gel – 30 g tube

ATC

Granulate:
M01AE02 - Anti-inflammatory, anti-rheumatic non-steroids drugs

Gel:
ATC M02AA12 - Topical anti-inflammatory non-steroids drug

Therapeutic Indications

Granulate:
Analgesic, antipyretic, long-acting anti-inflammatory and therefore it founds application in the treatment of arthritis and polyarthritis, rheumatoid arthritis, gouty arthropathy, ankylosing spondylitis, neuralgia, myalgia.

Gel:
In localized therapy of: muscle pain, bruises, sprains and muscle sprains, dislocations, hematomas, traumatic edema and infiltrates, fibromyositis, bursitis, tendinitis, tenosynovitis, periarthritis, phlebitis.
Adjuvant in orthopedic and rehabilitative therapies.

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.

Download area

Summary of Product Characteristics – Naprius Granules


Products of the same therapeutic areas

Events

06-07/12/2019

XVI CONGR NAZ FLEBOFORUM- XIV SIMPOSIO MALATTIA VARICOSA- VII FLEB WINTER FARM

NAPOLI

XVI CONGR NAZ FLEBOFORUM- XIV SIMPOSIO MALATTIA VARICOSA- VII FLEB WINTER FARM

 Download

08-10/11/2019

XXXII CONGRESSO NAZIONALE SNaMID

CATANIA

XXXII CONGRESSO NAZIONALE SNaMID